Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)
Issued by National Institutes of Health · via Grants.gov — US federal funding opportunities
- Published
- 26 Aug 2025
- Closes
- 10 Jan 2028, 23:59 UTC
- Reference
- RFA-HL-26-012
- Location
- United States
- Sector
- Healthcare & Pharma
At a glance
National Institutes of Health in United States has published a funding call in healthcare & pharma: “Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)”. Submissions close on 10 January 2028, 420 days from today. Quote reference RFA-HL-26-012 in any correspondence with the buyer. FreeTender has recorded 459 notices from this buyer since 2023, 367 of them currently open. There are 385 open healthcare & pharma notices in United States on FreeTender. Bids are submitted to the buyer through Grants.gov — US federal funding opportunities, not through FreeTender.
Key requirements
Taken from the notice by FreeTender. The tender document on the official portal is binding — check it, and any corrigendum, before you bid.
To bid on Grants.gov (US federal)
Applicants need a UEI from SAM.gov and a Grants.gov account registered to their organisation; allow several weeks for registration.
Details
The overall goal of the Stimulating Access to Research in Residency (StARR) program is to provide resident clinicians in training with in-depth research experiences early in their careers, in order to recruit, retain and accelerate independence of a pool of clinician-investigators with both clinical and research experience necessary to perform basic, clinical and/or translational research. Eligibility: Other Eligible Applicants include the following: Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
CFDA number(s): 93.837
Federal funding opportunity published on Grants.gov. Applications are submitted through Grants.gov — see the official listing.
Context for bidders
We hold 459 notices from National Institutes of Health, going back to May 2023 — 367 of them still open. They buy mostly in Healthcare & Pharma, Education & Training and Water & Environment. There are 385 open Healthcare & Pharma tenders in United States. This one closes in 420 days.
More from this buyer
- Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (UM1 Clinical Trial Required)· closes 10 Jun
- Research on System Support and Tools for Provider Training and Quality Monitoring for Suicide Preventive Care (RP1- Clinical Trial Optional)· closes 17 Feb
- NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)· closes 20 Feb
- The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) Scientific Data Research Center (U24 Clinical Trial Not Allowed)· closes 5 Mar
- George M. O’Brien Urology Cooperative Research Centers Program (U54 Clinical Trial Optional)· closes 1 Feb
Similar Healthcare & Pharma tenders
- Research Grants Supporting Scientific Discovery, Academic Research and New Studies· closes 18 Jan
- CFAs: Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (United States)· closes 10 Jun
- COMBINED SYNOPSIS/SOLICITATION/ (Brand Name or Equ· closes 1 Dec
- Smart Stretchers for the Hudson Valley, Castle Point VA Medical Center.· closes 20 Nov
- FCC Butner Pano X-Ray FY27 — Imaging Equipment and Supplies: Medical, Dental, Veterinary· closes 20 Nov
Explore United States
Before you bid on this tender
A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.
- Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
- Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
- Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
- Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
- Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
- Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
More Healthcare & Pharma tenders
- Поставка изделий медицинского назначенияГОСУДАРСТВЕННОЕ АВТОНОМНОЕ УЧРЕЖДЕНИЕ ЗДРАВООХРАНЕНИЯ СВЕРДЛОВСКОЙ ОБЛАСТИ "ГОРОДСКАЯ БОЛЬНИЦА ГОРОД КАМЕНСК-УРАЛЬСКИЙ" · Russia
- 1. КАРБОПЛАТИН (ОКПД2 21.20 – Препараты лекарственные и материалы, применяемые в медицинских целях), 2 250КРАЕВОЕ ГОСУДАРСТВЕННОЕ КАЗЕННОЕ УЧРЕЖДЕНИЕ "ЦЕНТР ГОСУДАРСТВЕННЫХ ЗАКУПОК ПРИМОРСКОГО КРАЯ" · Russia
- Поставка лекарственного препарата для медицинского применения ФулвестрантКРАЕВОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ ЗДРАВООХРАНЕНИЯ "КЛИНИКО-ДИАГНОСТИЧЕСКИЙ ЦЕНТР" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ ХАБАРОВСКОГО КРАЯ · Russia
- Поставка коагулятора в базовой комплектацииКРАЕВОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ "ХАБАРОВСКАЯ КРАЕВАЯ СТАНЦИЯ ПО БОРЬБЕ С БОЛЕЗНЯМИ ЖИВОТНЫХ" · Russia
- Поставка медицинских изделий для эндоваскулярной хирургииГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ ЗДРАВООХРАНЕНИЯ РЕСПУБЛИКИ КРЫМ "СИМФЕРОПОЛЬСКАЯ ГОРОДСКАЯ КЛИНИЧЕСКАЯ БОЛЬНИЦА №7" · Russia
FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.
Verify & apply on the official portal →